Item 9 Labs Corp (OTCMKTS:INLB) Stock Continues to Move Lower: Down 25% in a Month
Item 9 Labs Corp (OTCMKTS:INLB) stock continues to trend lower and extending its monthly fall to 25%. Will the stock rebound?
Market Action
In Thursday’s trading session, INLB stock ended lower by 5% at $1.59. More than 7.45k shares have exchanged hands, compared to its average volume of 18k shares. The stock opened at $1.68 and moved in a range of $1.5900 – 1.6900.
Item 9 Labs Corp. to Present at A.G.P.’s Virtual Fall Consumer Cannabis Conference October 5
Here are the highlights:
Generation Hemp, Inc. (the “Company”), a Dallas/Fort Worth based midstream hemp company (OTCQB: announced it will participate in the A.G.P. Virtual Fall Consumer Cannabis Conference on Tuesday, October 5, 2021.
The conference features up to 30 select companies in the cannabis industry and will be attended by approximately 200 qualified institutional investment funds from around the world.
The Company’s Chief Executive Officer Andrew Bowden, Chief Strategy Officer Jeffrey Rassas, and Chief Franchise Officer Mike Weinberger will be conducting one-on-one meetings with buy and sell-side analysts as well as qualified accredited investors to discuss:
the Company’s recently secured $19 million construction financing loan with Pelorus Equity Group,
development of its cultivation sites in Arizona and Nevada, national expansion of its cannabis dispensary franchise Unity Rd., operational excellence and performance of its high-quality Item 9 Labs products; and financial outlook into 2022.
Trader Notes:
INLB stock is trading below all the key moving averages with 200-day and 50-Day SMA stands at $2.91 and $2.02 respectively. Over the past year, the stock has lost over 20%. Will the stock be able to find the bottom and recover from the oversold zone?
